Pharmacogenomics: Ethical/Legal and Social Issues (ELSI)

Genomics & Health Impact Scan Database|Search|PHGKB

Publication
FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism FDA Press Release, October 31, 2018
Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective. Drozda Katarzyna et al. JACC. Basic to translational science 2018 Aug 3(4) 545-549 Similar articles in PubMed
The Ethical, Legal and Regulatory Issues Associated with Pharmacogenomics: Systematically Quantifying the Literature. Hewitt Jayne E et al. Journal of law and medicine 2018 Apr 25(3) 782-793 Similar articles in PubMed
Applications of pharmacogenomics in regulatory science: a product life cycle review. Tan-Koi W C et al. The pharmacogenomics journal 2017 Dec Similar articles in PubMed
Implementing Precision Medicine: The Ethical Challenges. Korngiebel Diane M et al. Trends in pharmacological sciences 2016 Dec Similar articles in PubMed
Pharmacogenomic Biomarkers: an FDA Perspective on Utilization in Biological Product Labeling. Schuck Robert N et al. The AAPS journal 2016 Feb Similar articles in PubMed
Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment. Tan-Koi W C et al. The pharmacogenomics journal 2016 Feb Similar articles in PubMed
Pharmacogenomics, human genetic diversity and the incorporation and rejection of color/race in Brazil. Santos Ricardo Ventura et al. Biosocieties 2015 Mar 1. 10(1) 48-69 Similar articles in PubMed
Ethical and public policy challenges for pharmacogenomics. Similar articles in PubMed